Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
Efficacy of transcranial alternating current stimulation on cognitive function in patients with dementia: a systematic review and meta-analysis of randomized controlled trials.
СтатьяСистематический обзорМетаанализОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tang Ying, Wang Yunhang, Li Wenyuan, Su Rong, Gao Tian, Ma Yuxia
Аннотация
BACKGROUND: Transcranial alternating current stimulation (tACS) has shown potential for improving cognitive function in dementia, but evidence remains inconsistent. This systematic review and meta-analysis aims to evaluate the efficacy of tACS on cognitive function in dementia.
METHODS: We searched seven databases for randomized controlled trials (RCTs) assessing tACS effects on cognitive function in dementia. Two reviewers independently screened the literature, extracted data, and assessed study quality. A random-effects model was used to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs). GRADE was used to rate evidence quality.
RESULTS: A total of 9 RCTs involving 357 patients with dementia were included. Compared with sham stimulation, tACS significantly improved immediate global cognition (SMD = 0.28; 95% CI [0.01, 0.54]; p = 0.04, I² = 39%), but not at follow-up. tACS also significantly improved immediate recall, delayed recall, and associative memory. Additionally, tACS significantly enhanced cholinergic transmission as measured by short-latency afferent inhibition (MD = 0.34, p < 0.001, I² = 0%). However, no significant effect was observed for neuropsychiatric symptoms, and the evidence for executive function was inconclusive. No serious adverse events occurred.
CONCLUSION: tACS may improve immediate global cognition and memory in patients with dementia, but no significant benefit was observed at follow-up or for neuropsychiatric symptoms. Findings are limited by few studies, heterogeneous parameters, and insufficient follow-up data. Future large, well-designed RCTs with standardized protocols are needed to optimize tACS parameters and confirm sustained efficacy.
METHODS: We searched seven databases for randomized controlled trials (RCTs) assessing tACS effects on cognitive function in dementia. Two reviewers independently screened the literature, extracted data, and assessed study quality. A random-effects model was used to calculate standardized mean differences (SMDs) with 95% confidence intervals (CIs). GRADE was used to rate evidence quality.
RESULTS: A total of 9 RCTs involving 357 patients with dementia were included. Compared with sham stimulation, tACS significantly improved immediate global cognition (SMD = 0.28; 95% CI [0.01, 0.54]; p = 0.04, I² = 39%), but not at follow-up. tACS also significantly improved immediate recall, delayed recall, and associative memory. Additionally, tACS significantly enhanced cholinergic transmission as measured by short-latency afferent inhibition (MD = 0.34, p < 0.001, I² = 0%). However, no significant effect was observed for neuropsychiatric symptoms, and the evidence for executive function was inconclusive. No serious adverse events occurred.
CONCLUSION: tACS may improve immediate global cognition and memory in patients with dementia, but no significant benefit was observed at follow-up or for neuropsychiatric symptoms. Findings are limited by few studies, heterogeneous parameters, and insufficient follow-up data. Future large, well-designed RCTs with standardized protocols are needed to optimize tACS parameters and confirm sustained efficacy.